Current Chemical Genomics and Translational Medicine

2008, 1 : 20-26
Published online 2008 February 25. DOI: 10.2174/1875397300801010020
Publisher ID: CCGTM-1-20

RESEARCH ARTICLE
Development of a HTRF® Kinase Assay for Determination of Syk Activity

Christopher Harbert, * , Jeannette Marshall , Sharon Soh and Krista Steger
Cisbio US Inc., 12 Deangelo Dr., Bedford MA 01730, USA

* Address correspondence to this author at the Cisbio US Inc., 12 Deangelo Dr., Bedford MA 01730, USA; Tel: (888) 963-4567; Fax: (781) 687-1298; E-mail: charbert@cisusinc.com

ABSTRACT

Regulation of protein phosphorylation is a primary cellular signaling mechanism. Many cellular responses to internal and external events are mitigated by protein kinase signaling cascades. Dysfunction of protein kinase activity has been linked to a variety of human pathologies, in the areas of cancer, inflammation, metabolism, cell cycle, apoptosis, as well as cardiovascular, neurodegenerative and autoimmune diseases [1-3]. As such, there is an important need for protein kinase activity detection methodologies for researchers engaged in Drug Discovery. A number of different technologies have been employed for the measurement of protein kinase activity, including radioactive methods, luminescent methods, and fluorescent methods. More recently, Homogeneous Time Resolved Fluorescence technology (HTRF®), based on the principle of time-resolved fluorescent resonance energy transfer (TR-FRET), has been developed and applied for the measurement of protein kinase activity in vitro. This technology note describes the development of an HTRF® assay for detection of Syk enzyme activity in a format consistent with the requirements of High-Throughput Screening (HTS) campaigns currently used in drug discovery.